Medicine and Dentistry
COVID-19
100%
Infection
84%
Severe Acute Respiratory Syndrome Coronavirus 2
82%
Cost-Effectiveness Analysis
70%
Analysis
62%
Health Care Cost
61%
Epidemic
49%
Vaccine
47%
Human Immunodeficiency Virus
41%
Health
35%
African Trypanosomiasis
34%
Hospital
32%
Antibiotic Resistance
32%
Influenza Vaccination
26%
Rotavirus
26%
Child
25%
Therapeutic Procedure
24%
Age
24%
Death
23%
Incidence
21%
Infant
21%
Human Respiratory Syncytial Virus
19%
Quality Adjusted Life Year
18%
Immunization
18%
Public Health
18%
Reproductive Medicine
18%
Adult
17%
Antibiotics
16%
Contact Examination
15%
Vector Control
15%
Schistosomiasis
14%
Patient
14%
Screening
14%
Pertussis
13%
Seasonal Influenza
13%
Motivation
13%
Meta-Analysis
13%
Dried Blood Spot
13%
Systematic Review
13%
Community Health
13%
Social Distancing
12%
Surveillance
11%
Obstetric Delivery
11%
Quarantine
11%
Non-Pharmaceutical Intervention
11%
School-Age Children
10%
Household
10%
Mortality
10%
Pathogen
10%
Statistical Modeling
9%
Nursing and Health Professions
Severe Acute Respiratory Syndrome
39%
Vaccination Policy
27%
Epidemic
20%
Analysis
20%
Immunization
19%
Hospital
17%
Infection
17%
Isolation
17%
Household
15%
Contact Examination
15%
Quarantine
13%
Ebola Hemorrhagic Fever
13%
Patient
13%
African Trypanosomiasis
13%
Cost Effectiveness Analysis
13%
Electric Potential
12%
Child
10%
Woman
9%
Incidence
9%
Control
9%
Screening
9%
Diseases
8%
Prediction
8%
Seasonal Influenza
7%
Influenza Vaccination
7%
Time
6%
Length of Stay
6%
Traveler
6%
Quality of Life
6%
Antibiotic Resistance
6%
Cholera
6%
Praziquantel
6%
Schistosomiasis
6%
Experiment
6%
Disease Transmission
6%
Respiratory Tract Disease
6%
Hospital Bed Utilization
6%
Virus Infection
6%
Monoclonal Antibody
6%
Older Adult
6%
Female
5%
Immunology and Microbiology
Dynamics
27%
Influenza
24%
Electric Potential
21%
Host
20%
Rotavirus
19%
Antimicrobial Resistance
19%
Human Respiratory Syncytial Virus
19%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Age
19%
Evolution
17%
Species
16%
Vaccine Efficacy
14%
Local Adaptation
13%
Gallid Alphaherpesvirus 2
13%
Virulence
12%
Infectious Agent
11%
Mortality
9%
Health
9%
Life
9%
Bacterium
8%
Virus
8%
Streptococcus Pneumoniae
8%
Monospecific Antibody
6%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
6%
Lineages
6%
Viral Disease
6%
Mortality Rate
6%
Nirsevimab
6%
Infectious Disease
6%
Herd Immunity
6%
Pneumococcus
6%
Human Immunodeficiency Virus
6%
Human Immunodeficiency Virus
6%
Interspecific Competition
6%
Monoclonal Antibody
6%
Gene
6%
Phylogeny
6%
COVID-19
6%
Gastroenteritis
5%
Time
5%
